Erich Kvas
Graz, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry.
Journal: Journal of neurology
Published: March 14, 2026
De-Escalation Treatment Strategies From Natalizumab in Patients With Relapsing Multiple Sclerosis in Austria.
Journal: European journal of neurology
Published: April 14, 2025
Early intensive versus escalation treatment in patients with relapsing-remitting multiple sclerosis in Austria.
Journal: Journal of neurology
Published: January 22, 2024
Effects of horizontal versus vertical switching of disease-modifying treatment after platform drugs on disease activity in patients with relapsing-remitting multiple sclerosis in Austria.
Journal: Journal of neurology
Published: January 24, 2023
Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients.
Journal: Frontiers in immunology
Published: June 01, 2021
Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis: real life data from the Austrian MS Treatment Registry.
Journal: Journal of neurology
Published: February 23, 2021
Oral therapies for treatment of relapsing-remitting multiple sclerosis in Austria: a 2-year comparison using an inverse probability weighting method.
Journal: Journal of neurology
Published: January 13, 2020
Correction to: Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry.
Journal: Journal of neurology
Published: September 19, 2019
Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry.
Journal: Journal of neurology
Published: May 24, 2019
Real-life use of oral disease-modifying treatments in Austria.
Journal: Acta neurologica Scandinavica
Published: October 28, 2018
Real-life clinical use of natalizumab and fingolimod in Austria.
Journal: Acta neurologica Scandinavica
Published: October 24, 2017
Safety and efficacy of periprocedural anticoagulation with enoxaparin in patients undergoing peripheral endovascular revascularization.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: June 21, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026